首页> 外文OA文献 >High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death
【2h】

High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death

机译:高峰期谷丙转氨酶决定了肝移植后非死亡性胆道狭窄的额外风险,循环死亡后捐献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Orthotopic liver transplantation (OLT) with donation after circulatory death (DCD) often leads to a higher first week peak alanine aminotransferase (ALT) and a higher rate of biliary nonanastomotic strictures (NAS) as compared to donation after brain death (DBD). This retrospective study was to evaluate whether an association exists between peak ALT and the development of NAS in OLT with livers from DBD (n=399) or DCD (n=97) from two transplantation centers. Optimal cutoff value of peak ALT for risk of development of NAS post-DCD-OLT was 1300IU/l. The 4-year cumulative incidence of NAS after DCD-OLT was 49.5% in patients with a high ALT peak post-OLT, compared with 11.3% in patients with a low ALT peak. (P
机译:与脑死亡后捐赠(DBD)相比,原发性肝移植(OLT)合并循环死亡(DCD)捐赠通常会导致更高的第一周峰值丙氨酸氨基转移酶(ALT)和更高的胆道非解剖性狭窄(NAS)率。这项回顾性研究旨在评估ALT峰值与OLT中NAS的发展与来自两个移植中心的DBD(n = 399)或DCD(n = 97)的肝脏之间是否存在关联。在DCD-OLT后发展NAS的风险中,ALT峰值的最佳临界值为1300IU / l。 OLT后ALT峰值高的患者DCD-OLT后4年NAS的累积累积发生率为49.5%,而ALT峰低的患者为41.3%。 (P

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号